Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Cancer Risk in Women Exposed to Diethylstilbestrol In Utero

Article Abstract:

Women who were exposed to diethylstilbestrol (DES) as fetuses do not appear to have a higher risk of cancer in general with the exception of clear cell adenocarcinoma (CCA) of the vagina and cervix. Researchers compared the incidence of cancer in 4,536 DES-exposed daughters and 1,544 unexposed daughters. The rate of cancer in general was no higher in the exposed daughters as the unexposed daughters with the exception of CCA. Exposed women had a CCA rate 41 times higher than women in the general population. An extended follow-up is needed as the average age of these women was only 38.

Author: Kaufman, Raymond H., Palmer, Julie R., Mittendorf, Robert, Robboy, Stanley J., Noller, Kenneth L., Hatch, Elizabeth F., Titus-Ernstoff, Linda, Hyer, Marianne
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Complications and side effects, Adenocarcinoma, Diethylstilbestrol

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cancer incidence before and after kidney transplantation

Article Abstract:

The incidence of cancer in patients receiving immune suppression after kidney transplantation was compared to cancer incidence during end-stage kidney disease before commencement of renal replacement therapy (RRT) and during dialysis in a population-based cohort study. Results revealed that cancer incidence is increased across a number of organ systems after kidney transplantation, suggesting an important role for the interaction between common viral infections and the immune system in the etiology of cancer.

Author: Kaldor, John M., Law, Matthew, Vajdic, Claire M., Margaret R.E., van Leeuwen, Marina T., Stewart, John H., Grulich, Andrew E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
Patient outcomes, Diagnosis, Renal replacement therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Smokers and breast cancer: 'chemical individuality' and cancer predisposition

Article Abstract:

Research showing an increased susceptibility to cancer in people who are fast or slow acetylators needs to be confirmed in larger studies. Many chemicals in the body are acetylated during their metabolism, which means that an enzyme adds an acetyl group to the chemical. People who have a mutation in the gene for this enzyme are called slow acetylators, which may predispose them to certain kinds of cancer. Fast acetylators can also be at increased risk because acetylation can turn a chemical into a carcinogen.

Author: Lin, Henry J.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
Health aspects, Editorial, Genetic aspects, Disease susceptibility, Acetylator status (Pharmacology)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Risk factors, Cancer
Similar abstracts:
  • Abstracts: Cover notes. White-knuckle ride to theatre. Evaluating the impact on patients of living with a leg ulcer
  • Abstracts: Carrier Rates in the Midwestern United States for GJB2 Mutations Causing Inherited Deafness. Trends in the association of poverty with overweight among US adolescents, 1971-2004
  • Abstracts: The economic burden of HIV in the United States in the era of highly active antiretroviral therapy. Increased risk of intrauterine transmission of HIV-1 associated with granulocyte elastase in endocervical mucus
  • Abstracts: The "Ambient Experience": Pediatric patients and diagnostic testing. Pay-for-performance: Will it work?
  • Abstracts: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Rabbit antithymocyte globulin versus basiliximab in renal transplantation
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.